Dibutyltryptamine

Dibutyltryptamine
Clinical data
Other namesDibutyltryptamine; DBT
ATC code
  • None
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class A
Identifiers
  • N-butyl-N-[2-(1H-indol-3-yl)ethyl]butan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC18H28N2
Molar mass272.436 g·mol−1
3D model (JSmol)
Melting point186 to 188 °C (367 to 370 °F)
  • CCCCN(CCCC)CCC1=CNC2=CC=CC=C21
  • InChI=1S/C18H28N2/c1-3-5-12-20(13-6-4-2)14-11-16-15-19-18-10-8-7-9-17(16)18/h7-10,15,19H,3-6,11-14H2,1-2H3 Y
  • Key:LZLJUZWFWYEQLY-UHFFFAOYSA-N Y
  (verify)

N,N-Dibutyltryptamine (DBT) is a psychedelic drug belonging to the tryptamine family. DBT was synthesized by the chemist Alexander Shulgin and described in his book TiHKAL (Tryptamines i Have Known And Loved).

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.